Bruker Cellular Analysis Competitors and Similar CompaniesClear all
Sangamo Therapeutics's competitors and similar companies include Crescendo Biologics.
 Sangamo Therapeutics Sangamo Therapeutics (formerly known as Sangamo BioSciences) is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies. |  Crescendo Biologics Crescendo Biologics is a provider of human VH antibody fragment therapeutics created to optimize antibodies and a transgenic mouse which produces heavy chain only antibodies. | |
Founding Date | Founding Date 1995 | Founding Date 2007 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Brisbane, US HQ Nice Area, FR Cheltenham, GB London, GB Richmond, US | Locations Babraham, GB HQ |
Employees | Employees 35417% increase | Employees 12 |
Financial | ||
Revenue (est.) | Revenue (est.) $39.6m (FY, 2025) | Revenue (est.) £7.5m (FY, 2018) |
Net income | Net income ($122.9m) (FY, 2025) | Net income (£1.8m) (FY, 2018) |
Funding | ||
Total funding raised | Total funding raised $ 74.2m | Total funding raised $ 116.2m |
For sources of this data, please see the company profile
View Company Profiles
Crescendo Biologics
HQ
Babraham, GB
Employees
12
Crescendo Biologics is a provider of human VH antibody fragment therapeutics created to optimize antibodies and a transgenic mouse which produces heavy chain only antibodies.
View company